Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
601
-
Total 13F shares, excl. options
-
72M
-
Shares change
-
+769K
-
Total reported value, excl. options
-
$24.8B
-
Value change
-
+$207M
-
Put/Call ratio
-
1.39
-
Number of buys
-
294
-
Number of sells
-
-297
-
Price
-
$344.36
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2018
759 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2018.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 601 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72M shares
of 105M outstanding shares and own 68.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6M shares), VANGUARD GROUP INC (5.61M shares), FMR LLC (5.18M shares), Capital World Investors (4.7M shares), WELLINGTON MANAGEMENT GROUP LLP (4.32M shares), STATE STREET CORP (3.3M shares), LOOMIS SAYLES & CO L P (2.82M shares), SANDS CAPITAL MANAGEMENT, LLC (2.4M shares), HARRIS ASSOCIATES L P (1.7M shares), and JANUS HENDERSON GROUP PLC (1.6M shares).
This table shows the top 601 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.